GlassScriptPhysician profile
Steven P Ash
NPI 1326072299
$5,633.51
in general payments reported to CMS, 2019-2025
43 companies · $1,903 in 2025
The $1,903 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $695 · 2021: $942 · 2022: $484 · 2023: $777 · 2024: $279 · 2025: $1,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,970 · Travel and Lodging: $790 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,969.51 |
| Travel and Lodging | $790.18 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $968.87 | 2025 | |
| Astellas Pharma US INC | $560.58 | 2019-2023 | Veozah |
| Antares Pharma, INC. | $556.48 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $400.80 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Boston Scientific Corporation | $338.43 | 2019-2022 | |
| Abbvie INC. | $299.22 | 2019-2025 | Lupron Depot, Botox |
| Pfizer INC. | $243.54 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $222.98 | 2020-2023 | Aveed, Xiaflex |
| Myovant Sciences INC. | $188.73 | 2021-2022 | |
| Avation Medical, INC. | $184.08 | 2024-2025 | Vivally System, Vivally |
| Accord Healthcare, INC. | $148.95 | 2022-2023 | |
| Verity Pharmaceuticals INC. | $139.89 | 2024-2025 | Trelstar, Tlando |
| Blue Earth Diagnostics | $134.40 | 2020-2025 | Posluma |
| Alnylam Pharmaceuticals INC. | $128.70 | 2021-2023 | Oxlumo |
| Clarus Therapeutics INC. | $106.01 | 2021 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $84.44 | 2020-2023 | Axonics |
| Endo USA, INC. | $69.58 | 2024-2025 | Xiaflex, Aveed |
| Isoray, INC | $67.61 | 2020 | |
| Merck Sharp & Dohme LLC | $62.52 | 2020-2023 | Lynparza, Keytruda |
| Olympus America INC. | $61.64 | 2023-2025 | Itind System |
| Coloplast Corp | $56.60 | 2020-2023 | Speedicath |
| Neotract INC. | $52.07 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $49.32 | 2023 | Seglentis |
| Urogen Pharma, INC. | $48.51 | 2023-2025 | Jelmyto |
| Photocure INC | $48.34 | 2023-2025 | Cysview |
| Laborie Medical Technologies Corp. | $47.94 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $44.61 | 2021-2025 | |
| Travere Therapeutics, INC. | $38.30 | 2020-2021 | |
| Telix Pharmaceuticals | $29.19 | 2025 | Illuccix |
| Novo Nordisk INC | $28.80 | 2025 | Rivfloza |
| Civco Medical Instruments | $28.12 | 2025 | |
| 180 Medical, INC. | $26.68 | 2023 | Gentlecath |
| Convatec INC. | $24.74 | 2023 | |
| Teleflex LLC | $19.27 | 2025 | Deknatel |
| Myriad Genetic Laboratories, INC. | $18.93 | 2025 | Prolaris |
| Azurity Pharmaceuticals, INC. | $16.07 | 2025 | Azmiro |
| Halozyme INC | $16.04 | 2023 | |
| Allergan, INC. | $14.25 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $13.48 | 2020 | |
| Zyla Life Sciences, INC. | $13.18 | 2020 | |
| Acerus Pharmaceuticals Corporation | $12.39 | 2020 | |
| Urovant Sciences INC | $11.58 | 2021 | |
| Mission Pharmacal Company | $7.65 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Ash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.